{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:34:15Z","timestamp":1792611255913,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jhepr.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T03:05:18Z","timestamp":1557457518000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2781-5088","authenticated-orcid":false,"given":"Felix","family":"Piecha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf K.","family":"Radunski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Ozga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Steins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Drolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Horvatits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Spink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Ittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Benten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sinning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kluwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2019.04.001_bb0005","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0020","first-page":"55","article-title":"Management of compensated liver cirrhosis 2018 - Evidence based prophylactic measures","volume":"56","author":"Karkmann","year":"2018","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","article-title":"Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial","volume":"46","author":"Narahara","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0035","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"Rossle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0045","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0065","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2010.08.025","article-title":"Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS","volume":"54","author":"Bureau","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","article-title":"TIPS: 25 years later","volume":"59","author":"Rossle","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0080","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/ajg.2009.321","article-title":"The use of E\/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt","volume":"104","author":"Rabie","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0085","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1572-0241.2003.08664.x","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0090","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","article-title":"The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites","volume":"332","author":"Ochs","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/hepr.12195","article-title":"Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites","volume":"44","author":"Taki","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/ajr.165.1.7785564","article-title":"Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis","volume":"165","author":"Foshager","year":"1995","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0105","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/j.gastro.2017.01.011","article-title":"Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension","volume":"152","author":"Silva-Junior","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jvir.2016.06.023","article-title":"Prospective Evaluation of Passive Expansion of Partially Dilated Transjugular Intrahepatic Portosystemic Shunt Stent Grafts-A Three-Dimensional Sonography Study","volume":"28","author":"Pieper","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","article-title":"Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis","volume":"16","author":"Schepis","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0120","first-page":"2","article-title":"Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Looking for the Right Patient and the Right Time","volume":"6","author":"Senzolo","year":"2018","journal-title":"EMJ Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0125","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.RVI.0000240651.38289.4B","article-title":"Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites","volume":"17","author":"Harrod-Kim","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1572-0241.1999.01112.x","article-title":"Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites","volume":"94","author":"Deschenes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0145","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1627457","article-title":"Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?","volume":"38","author":"Trebicka","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hep4.1337","article-title":"Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct-Acting Antiviral Treatment Failure in Patients With Hepatitis C?","volume":"3","author":"Piecha","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0160","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0165","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/liv.13610","article-title":"Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality","volume":"38","author":"Lehmann","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2014.09.032","article-title":"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"62","author":"Berres","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/liv.12922","article-title":"Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt","volume":"36","author":"Berres","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0180","doi-asserted-by":"crossref","first-page":"G945","DOI":"10.1152\/ajpgi.00399.2015","article-title":"Arterial pressure suffices to increase liver stiffness","volume":"311","author":"Piecha","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0185","doi-asserted-by":"crossref","first-page":"G179","DOI":"10.1152\/ajpgi.00239.2017","article-title":"Rapid change of liver stiffness after variceal ligation and TIPS implantation","volume":"314","author":"Piecha","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.dld.2017.09.138","article-title":"Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation","volume":"50","author":"Buechter","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0195","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/hep.29612","article-title":"Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality","volume":"67","author":"Jansen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0200","doi-asserted-by":"crossref","first-page":"G484","DOI":"10.1152\/ajpgi.00392.2017","article-title":"Pharmacological decrease of liver stiffness is pressure-related and predicts long term clinical outcome","volume":"315","author":"Piecha","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0205","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.001_bb0210","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis","volume":"154","author":"Simon-Talero","year":"2018","journal-title":"Gastroenterology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955591930031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955591930031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:48Z","timestamp":1762899768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955591930031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S258955591930031X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.04.001","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}]}}